MEI Pharma, Inc. Common Stock
LITSStockNASDAQ
$0.74 ▲ +0.00%
Jun 12, 2026
L
MEI Pharma, Inc. Common Stock
$0.74 ▲ +0.00%
Jun 12, 2026
LITSStockNASDAQ

About the company

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

Arberion
Loading market data